Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05203315 · ClinicalTrials.gov registry record · Phase 3
Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults
A Phase 3 study, sponsored by Austin Institute for Clinical Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 21
- Enrollment target
NCT05203315 is a Phase 3 study that has completed, run by Austin Institute for Clinical Research. The registered enrollment target is 21 participants.
The verdict
NCT05203315, a Phase 3 study, has completed, sponsored by Austin Institute for Clinical Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study seeks to evaluate the safety, tolerability, and efficacy of topical Duobrii® Lotion in adult subjects with mild plaque psoriasis.
Interventions
- DRUG Duobrii 0.01 % / 0.045 % Topical Lotion
- DRUG CeraVe, Topical Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2022-01-13 |
| Est. Completion | 2023-10-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05203315
The ClinicalTrials.gov registry entry for NCT05203315 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Austin Institute for Clinical Research, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Duobrii 0.01 % / 0.045 % Topical Lotion is the first listed.
NCT05203315 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05203315 about?
NCT05203315 is a clinical study titled "Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults". This study seeks to evaluate the safety, tolerability, and efficacy of topical Duobrii® Lotion in adult subjects with mild plaque psoriasis.
What is the current status of trial NCT05203315?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 21 participants. The study started on 2022-01-13. Estimated completion is 2023-10-04.
What interventions are being tested in trial NCT05203315?
The interventions under investigation include: Duobrii 0.01 % / 0.045 % Topical Lotion (DRUG), CeraVe, Topical Cream (DRUG).
Who is sponsoring clinical trial NCT05203315?
This trial is sponsored by Austin Institute for Clinical Research, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.